288330 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Bridge Biotherapeutics, Inc. is engaged in the manufacturing of pharmaceutical products. It also engages in the provision pharmacy research, development and experiment of medicines. The company was founded by Jeong-Gyu, Lee on September 17, 2015 and is headquartered in Seongnam-si, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
288330 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company